New Leaf Venture Partners
Venture capitalNew York · Seed–Late Stage · 5 people tracked
Also known as NEW LEAF VENTURE PARTNERS LLC
Investment thesis
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Source: firm website, verified Jul 30, 2026.
Team · 5 people
from public directories
What they invest in
from 4 of 9 portfolio companiesHealthtech ×3AI & Machine Learning ×2Medical Devices ×2Biotech ×1Enterprise Software ×1
HQs:United States×9
Investments · 9 tracked
founders shown can be your intro pathBy year:2022 · 12017 · 32016 · 32015 · 12014 · 19 dated
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Kevin M. King(Executive Officer, Director)Tiba Aynechi(Director)Joshua L. Green(Director)Casper de Clercq(Director)Chris E. Grant(Director)William N. Starling(Director)
Board seatVijay Lathi· per SEC Form D · $29.5M raise · filed Mar 2015
New York, US
Michael Liang(Director)Vijay Lathi(Director)Gordon Kessler(Executive Officer)Rick Hawkins(Director)Adam Hanina(Executive Officer, Director)
Board seatVijay Lathi· per SEC Form D · $12M raise · filed Jul 2017
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Thomas Mawhinney(Director)Brandon Hull(Director)Vijay Lathi(Director)Brian Ascher(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)
Board seatVijay Lathi· per SEC Form D · $1.9M raise · filed Aug 2017
Denver, US
Board seatVijay Lathi· per SEC Form D · $16.8M raise · filed Mar 2022
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects.
HealthtechMedical DevicesWoburn, US
Jeani Delagardelle(Director)Gregory H. Lambrecht(Director)Brian Verrier(Director)Joshua Makower(Director)Carey Hagan(Executive Officer, Director)Kevin Sidow(Director)
Board seatJeani Delagardelle· per SEC Form D · $7.5M raise · filed Apr 2023
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtech
Kevin MacDonald(Executive Officer)Timothy Kress-Spatz(Executive Officer)
Board seatVijay Lathi· per SEC Form D · filed Jun 2016
Boston, US
Board seatVijay Lathi· per SEC Form D · $10M raise · filed Feb 2017
BiotechSan Clemente, US
John Lehmann, M.D.(Director)Casey Tansey(Director)Jeani Delagardelle(Director)Kenneth Charhut(Director)Richard Thompson(Executive Officer, Director)Bruce Feuchter(Executive Officer)
Board seatJeani Delagardelle· per SEC Form D · $8.8M raise · filed Mar 2015
Data-driven platform bringing transparency to prescription drug ecosystem for employers, retailers, and manufacturers.
New York, US
Philippe Chambon(Director)Stephen M. Bloch(Director)Brian Hirsch(Director)Michael Facendola(Executive Officer)Marcia Radosevich(Executive Officer)Leon Greene(Director)
Board seatVijay Lathi· per SEC Form D · $34.7M raise · filed Aug 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioIrhythmtechNASDAQ: IRTC
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does New Leaf Venture Partners invest at?
- New Leaf Venture Partners invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does New Leaf Venture Partners focus on?
- New Leaf Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is New Leaf Venture Partners located?
- New Leaf Venture Partners is headquartered in New York, US.
Co-investors · 19
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Goodwater Capital is a consumer technology investment firm backing entrepreneurs building companies across sectors such as housing, healthcare, food delivery, financial services, education, entertainment, and transportation.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
Versant Ventures operates in-house Discovery Engines staffed by multidisciplinary scientists in dedicated laboratory facilities to help launch new biotechnology companies alongside academic founders.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Domain Associates (DomainVC) is a life sciences venture capital firm that served as investment advisors to the first VC fund dedicated to biotech and as investment manager of nine subsequent biotech VC funds.
▶7 more co-investors
SV Health InvestorsFrazier Healthcare PartnersNextech InvestLightstone VenturesVantagePoint Capital PartnersBain Capital Life Sciences4see Ventures
Firms observed investing alongside New Leaf Venture Partners, from public investor directories. Shared companies are the overlap with New Leaf Venture Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.